Cardiac Rehab Effects in HFpEF
Efficacy of Exercise Training in Patients With HFpEF
1 other identifier
interventional
45
1 country
1
Brief Summary
This research in Veterans with heart failure with preserved ejection fraction (HFpEF) will provide new information on the mechanisms determining the patients' exercise intolerance and the efficacy of regular physical activity to improve this shortcoming by alleviating the patients' neurocirculatory abnormalities. Specifically, the investigators will focus on the role of nerves originating in working limb muscles in determining the patients' exercise intolerance and compromised fatigue resistance before and after a chronic exercise intervention. By focusing on a specific mechanism, this project will evaluate the validity of exercise as an alternative treatment strategy with the overall purpose of improving the quality of life of Veterans with HFpEF.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 6, 2020
CompletedFirst Posted
Study publicly available on registry
August 10, 2020
CompletedStudy Start
First participant enrolled
May 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
March 19, 2026
March 1, 2026
4.4 years
August 6, 2020
March 16, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
femoral blood flow
Quantifying femoral blood flow during exercise with and without afferent blockade
1 hour
Secondary Outcomes (1)
femoral blood flow
12 weeks
Study Arms (3)
Afferent effect on hemodynamics
EXPERIMENTALEvaluate impact of group III/IV muscle afferents on femoral blood flow
Afferent effect on fatigue
EXPERIMENTALEvaluate impact of group III/IV muscle afferents on exercise-induced changes in quadriceps twitch force
Effect of cardiac rehab
EXPERIMENTALEvaluate effect of chronic exercise on influence of muscle afferents on limb blood flow
Interventions
Block sensory feedback to evaluate hemodynamic and fatigue consequence of group III/IV muscle afferents
Eligibility Criteria
You may qualify if:
- heart failure with preserved ejection fraction
You may not qualify if:
- heart failure with reduced ejection fraction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Salt Lake City Health Care System, Salt Lake City, UT
Salt Lake City, Utah, 84148-0001, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Markus Amann, PhD
VA Salt Lake City Health Care System, Salt Lake City, UT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 6, 2020
First Posted
August 10, 2020
Study Start
May 2, 2022
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
September 30, 2026
Last Updated
March 19, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share